Poster 58
- Kelley Tangredi
- May 7, 2023
- 1 min read
Updated: Jul 8, 2023
Patients’ Quality of Life in a Phase 4 Real-World Study of Tildrakizumab in Moderate-to-Severe Plaque Psoriasis
Authors: Jayme Heim, J Gabriel Vasquez, Ranga Gogineni, Brad Schenkel, Neal Bhatia
Comments